Product Candidate

Disease Indication

Current Stage of Development

Delayed release, enteric-coated cysteamine bitartrate
(DR Cysteamine)

Nephropathic Cystinosis

Phase II
(ongoing, open IND )
Orphan Product Designation

DR Cysteamine

Non-Alcoholic Steatohepatitis
(NASH)

Phase IIa
(pending, open IND)

DR Cysteamine

Huntington’s Disease

Phase II
(planned)

DR Cysteamine

Batten Disease

Phase II
(planned)

Convivia™

Aldehyde Dehydrogenase (ALDH2) Deficiency

Phase IIa
(planned, IND filed)

HepTide™

Hepatocellular Carcinoma
(HCC)

Preclinical
(ongoing)

HepTide™

Hepatitis C

Preclinical
(ongoing)

WntTide™

Breast Cancer

Preclinical
(ongoing)

NeuroTrans™

Neurodegenerative Diseases

Preclinical
(ongoing)